Copyright © Inderes 2011 - present. All rights reserved.

Optomed

3.82 EUR

+4.80 %

5,573 following

OPTOMED

NASDAQ Helsinki

Medical Equipment & Services

Health Care

+4.80 %
-6.83 %
+1.73 %
-4.74 %
-18.03 %
-14.16 %
+7.00 %
-46.57 %
-16.59 %

Optomed operates in the medical technology sector. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that are resold under different brands. Operations are held on a global level, with the largest presence in the Nordic market. Customers consist of research institutes and hospitals. The company has its headquarters in Oulu.

Read more
Market cap
75.23M EUR
Turnover
369.85K EUR
P/E (adj.) (25e)
-12.51
EV/EBIT (adj.) (25e)
-14.53
P/B (25e)
4.15
EV/S (25e)
4.28
Dividend yield-% (25e)
-
Coverage
Recommendation
Buy
Target price
5.20 EUR
Updated
07.11.2025
Disclaimer
Juha Kinnunen
Juha Kinnunen

Analyst

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
10.2
2026

Annual report '25

6.5
2026

Interim report Q1'26

8.5
2026

General meeting '26

Risk
Business risk
Valuation risk
Low
High
ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
Expansion contract for the software side, delivery Q1/2026. The price is likely 6-digit, and so is the annual maintenance. hankintailmoitukset.fi Hilma
yesterday
by Sheikki
56
In the US, the administration is seriously committed to leveraging AI in healthcare. https://www.wilx.com – 5 Dec 25 US health department unveils strategy to expand its adoption of AI technology The U.S. Department of Health and Human Services has outlined a new strategy to expand...
6 hours ago
by Sheikki
29
“AI can help improve equity and access to care across underserved and high-risk communities. HHS will prioritize AI-enabled tools that support care delivery in rural areas, low-income populations, and other communities with limited access to traditional healthcare” “AI-enabled screening...
5 hours ago
by Mr. Stock
23
Aurora IQ now also available in Armenia optotech.am Optomed Aurora IQ — Portable Non-Mydriatic Handheld Fundus Camera Portable handheld fundus camera offering high-quality retinal and anterior eye imaging. Optotech is one of the leading companies in Armenia specializing in the import...
yesterday
by Maximus
22
Oh, it must be delivered and in use by the beginning of February at the latest. This acquisition has been a bit late (waiting for the budget?) “The screening system must be in use by the beginning of February 2026 at the latest, because otherwise statutory screenings cannot be carried...
23 hours ago
21
It is also specifically mentioned that priorities and common diseases where AI is truly beneficial are identified, the list includes “heart disease (Toku)” and “diabetes (aurora aeye)”. ”Strategic Goals Identify priority conditions and public health issues (e.g., heart disease, cancer...
5 hours ago
11
Regulation and guidance from the Indian Ministry of Health on 5.12.2025 regarding the use of AI in retinopathy imaging. The camera was not mentioned, but the AI tool “MadhuNetrAI” was. One would think there would be a use for a portable camera in border areas too. A few customers...
4 hours ago
by TJ-Groupin Tuulipuku
9
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.